Product NDC: | 53808-0447 |
Proprietary Name: | Levothyroxine Sodium |
Non Proprietary Name: | Levothyroxine Sodium |
Active Ingredient(s): | .075 mg/1 & nbsp; Levothyroxine Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53808-0447 |
Labeler Name: | State of Florida DOH Central Pharmacy |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021210 |
Marketing Category: | NDA |
Start Marketing Date: | 20090701 |
Package NDC: | 53808-0447-1 |
Package Description: | 30 TABLET in 1 BLISTER PACK (53808-0447-1) |
NDC Code | 53808-0447-1 |
Proprietary Name | Levothyroxine Sodium |
Package Description | 30 TABLET in 1 BLISTER PACK (53808-0447-1) |
Product NDC | 53808-0447 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levothyroxine Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090701 |
Marketing Category Name | NDA |
Labeler Name | State of Florida DOH Central Pharmacy |
Substance Name | LEVOTHYROXINE SODIUM |
Strength Number | .075 |
Strength Unit | mg/1 |
Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |